Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Greenhalf

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
BMJ Open|April 3, 2025
European Registry of Hereditary Pancreatic Diseases (EUROPAC): protocol for primary and secondary screening in individuals with inherited pancreatic disease syndromes for pancreatic ductal adenocarcinoma and complications of other pancreatic diseasesAnnabelle Boughey, Phil Hopley, Ioannis Sarantitis, et al.
Ebiomedicine|October 20, 2019
Natural history of SPINK1 germline mutation related-pancreatitisNelly Muller, Ioannis Sarantitis, Marie Rouanet, et al.
Molecular Cancer Therapeutics|January 16, 2016
Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to InhibitorsJosé M Mazarico, Victor J Sánchez-Arévalo Lobo, Rosy Favicchio, et al.
Oncotarget|September 26, 2018
Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarkerNeus Martinez-Bosch, Luis E Barranco, Carlos A Orozco, et al.
Ebiomedicine|January 6, 2022
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetesLucy Oldfield, Anthony Evans, Rohith Gopala Rao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Evaluation of the 4q32-34 locus in European familial pancreatic cancerJulie Earl, Li Yan, Louis J Vitone, et al.
BMJ Open|October 10, 2022
United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancerLucy Oldfield, Martyn Stott, Robert Hanson, et al.
British Journal of Cancer|September 2, 2016
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancerJörg Kleeff, Eithne Costello, Richard Jackson, et al.
The Lancet. Gastroenterology & Hepatology|March 6, 2020
Early detection of pancreatic cancerStephen P Pereira, Lucy Oldfield, Alexander Ney, et al.
Annals of Surgery|November 29, 2016
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical TrialTalar Tatarian, Wei Jiang, Benjamin E Leiby, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
BMJ Open|April 3, 2025
European Registry of Hereditary Pancreatic Diseases (EUROPAC): protocol for primary and secondary screening in individuals with inherited pancreatic disease syndromes for pancreatic ductal adenocarcinoma and complications of other pancreatic diseasesAnnabelle Boughey, Phil Hopley, Ioannis Sarantitis, et al.
Ebiomedicine|October 20, 2019
Natural history of SPINK1 germline mutation related-pancreatitisNelly Muller, Ioannis Sarantitis, Marie Rouanet, et al.
Molecular Cancer Therapeutics|January 16, 2016
Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to InhibitorsJosé M Mazarico, Victor J Sánchez-Arévalo Lobo, Rosy Favicchio, et al.
Oncotarget|September 26, 2018
Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarkerNeus Martinez-Bosch, Luis E Barranco, Carlos A Orozco, et al.
Ebiomedicine|January 6, 2022
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetesLucy Oldfield, Anthony Evans, Rohith Gopala Rao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Evaluation of the 4q32-34 locus in European familial pancreatic cancerJulie Earl, Li Yan, Louis J Vitone, et al.
BMJ Open|October 10, 2022
United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancerLucy Oldfield, Martyn Stott, Robert Hanson, et al.
British Journal of Cancer|September 2, 2016
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancerJörg Kleeff, Eithne Costello, Richard Jackson, et al.
The Lancet. Gastroenterology & Hepatology|March 6, 2020
Early detection of pancreatic cancerStephen P Pereira, Lucy Oldfield, Alexander Ney, et al.
Annals of Surgery|November 29, 2016
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical TrialTalar Tatarian, Wei Jiang, Benjamin E Leiby, et al.
Pageof 13